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The severity of respiratory syncytial virus (RSV) infections appears to differ with age in both
humans and bovines. A primary RSV infection in naı¨ve infants and in young calves runs a more
severe course when they are 1–6 months old than in their first month of life. The relative lack of
clinical signs in the first month of age may be due to high levels of maternally derived neutralizing
antibodies or low exposure to infectious virus. This study examined whether age-dependent
differences in the pathogenesis of bovine RSV (bRSV) between neonatal and young calves may
be due to differences in age-dependent immunocompetence. To study the effect of age and
immune parameters on bRSV disease in neonatal and young calves, neonatal (1-day-old) calves
without maternally derived antibodies were infected experimentally with bRSV and the severity of
disease and immune responses were evaluated in comparison with disease in similar 6-week-old
infected calves. Neonatal calves had more extensive virus replication and lung consolidation, but
lower pro-inflammatory [in particular tumour necrosis factor alpha (TNF-a)] responses, specific
humoral immune responses, lung neutrophilic infiltration and clinical signs of disease than 6-
week-old calves. The lack of correlation between virus replication and clinical signs suggests an
important role of pro-inflammatory cytokines, in particular TNF-a, in the disease. The capacity to
produce pro-inflammatory TNF-a appeared to increase with age, and may explain the age-
dependent differences in RSV pathogenesis.
INTRODUCTION
Bovine respiratory syncytial virus (bRSV) is one of the major
causes of bovine respiratory disease (BRD). BRD results from
a complex, multifactorial interaction of stressors, animal
susceptibility and respiratory pathogens, and is probably one
of the most common and costly diseases of feedlot and dairy
cattle worldwide (Snowder et al., 2006). Apparently healthy
calves harbour potentially pathogenic bacteria in their
respiratory tract waiting for viruses to pave their way to
invasive infection, causing BRD (Angen et al., 2009; Babiuk et
al., 1988). bRSV is considered endemic in Europe, and
infections with bRSV are one of the most common diseases
in the first years of life of cattle, with the highest incidence in
autumn and winter (Van der Poel et al., 1994). In fact, by
2 years of age, the seroprevalence of antibodies against
bRSV is .70%. Nevertheless, bRSV reinfection can occur
throughout life, although becoming progressively less severe
with the increase in age.
In vivo, bRSV primarily targets the respiratory epithelium in
the nasopharynx, bronchi, bronchioles and alveolar spaces.
Clinical signs are characterized by general illness (pyrexia,
anorexia and depression), upper respiratory tract disease
(URTD; nasal and ocular discharge and cough) and lower
respiratory tract disease (LRTD; tachypnoea and, in severe
cases, dyspnoea). Although in many cases the lower
respiratory tract is involved in infection, the clinical signs
may remain limited to the upper respiratory tract (Verhoeff
et al., 1984). Age has always been identified as an important
risk factor for development of the more severe (lower)
respiratory tract disease. Severe, life-threatening LRTD is
seen mostly during (primary) infection in 1–6-month-old
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calves (Bryson et al., 1978; Kimman et al., 1988). Strikingly,
newborns are generally not severely affected. These observa-
tions have led to the hypothesis that these very young calves are
well protected by, for example, passively acquired maternally
derived antibodies (Kimman et al., 1988). Kimman et al.
(1988) showed that the severity of disease was inversely related
to the level of maternal antibodies in calves from 1 to 3 months
old, suggestive of a role of immunopathogenic mechanisms. In
contrast, Tjørnehøj et al. (2003) showed that there was no
correlation between the neutralizing antibody titre at inocu-
lation and the peak respiratory rate/severity of elicited
pneumonia in calves of 2–5 months of age.
Thus, severe disease appears to be observed less often in
older calves, but on the other hand seems to be practically
absent in calves younger than 2 weeks, irrespective of the
maternal antibody titre (Baker et al., 1986). Kimman et al.
(1988) suggested that, in these newborn calves, exposure to
the virus is lower during the first 10–14 days of their lives
due to their individual housing and to them not experi-
encing the entire period of bRSV circulation on the farm.
In the present study, we hypothesized that age-dependent
differences in the pathogenesis of bRSV in neonatal and
young calves are due to differences in immunocompetence.
We therefore examined the effect of bRSV inoculation in
neonatal (1-day-old) and young (6-week-old) calves in the
absence of maternal antibodies and evaluated the severity
of disease and bRSV immune responses in both groups.
RESULTS
bRSV shedding and specific humoral immune
responses after inoculation
To assess the impact of age on severity of disease, 1-day-old
neonates were infected by intranasal inoculation of
103.4 TCID50 bRSV strain Odijk and compared with 6-
week-old (‘young’) calves. As expected, bRSV was isolated
from the upper respiratory tract in all calves, but the
neonates shed virus for significantly longer than the young
calves [mean±SEM, 5.6±0.5 vs 3.8±0.8 days post-infection
(p.i.), P50.0238; Fig. 1]. The magnitude of virus excretion
was calculated as the area under the curve. The mean virus
excretion in young calves was 12.14±2.03 versus 14.26±
2.75 TCID50 ml
21 in neonates. Infectious bRSV was isolated
from day 6 lung washes in three (two young and one
neonatal) calves. All young calves seroconverted by 13 days
p.i., whereas three of the neonates remained serologically
negative (mean virus neutralizing antibody titre¡2) for the
duration of the experiment. Young calves developed
significantly more neutralizing antibodies than the neonates
(Fig. 2; P50.0087).
Clinical signs after bRSV infection
The calves were monitored clinically for 13 days after
infection, at which point the experiment was terminated.
Parameters evaluated were categorized as general illness,
URTD and LRTD (Fig. 3). None of the neonates was
scored as generally ill, whereas three of five young calves
were scored as generally ill for 1–3 days. This was
confirmed by assessment of rectal temperatures. Whilst
four of five young calves had fever (rectal temperature
.39.6 uC) for 1–4 days, none of the neonates had fever.
These differences were statistically significant (P,0.05).
Signs of URTD were observed in all calves in both age
groups. A moderate URTD (score 2) was observed in all
neonates from day 5 p.i. for 2–4 days (mean 2.8±0.8 days)
and in all young calves from day 6 p.i. for 2–6 days (mean
Fig. 1. Mean (±SEM) virus titre in nasopharyngeal fluid samples
per group from day 0 (prior to infection) up to 10 days p.i.&, Six-
week-old young calves; g, 1-day-old neonates. Neonates shed
virus for significantly longer than the young calves (5.6±0.5 vs
3.8±0.8 days, P50.0238).
Fig. 2. Mean virus-neutralizing antibody titres (±SEM) per group,
measured at day 0 (prior to infection), day 7 p.i. and at the end of
the study (day 13 p.i.). &, Six-week-old young calves; g, 1-day-
old neonates. Antibody titres are expressed as reciprocal values of
the highest neutralizing dilution. Starting at a 1 : 4 dilution, ¡2
(1 log2) was considered to be negative. Six-week-old calves had
significantly more neutralizing antibodies than 1-day-old calves
(P50.0087) at 13 days p.i.
A. F. G. Antonis and others
2498 Journal of General Virology 91
4.6±1.5 days). Severe URTD (score 3) was scored four
times in three calves in the young calves group, and twice in
two calves in the neonates group. LRTD was scored in all
young calves and in four of five neonates. Severe LRTD was
observed in only two young calves for 1–3 days, resulting in
a significant difference (P,0.001) on day 7 p.i. between
the groups. A significantly higher number of days with
tachypnoea, defined as .40 breaths min21, was observed in
the young calves group compared with the neonates (mean
4.8±1.6 vs 2.0±1.3 days, P,0.05).
Characteristics of inflammatory responses in
peripheral blood and in the lungs
Phenotypic analysis of the cells migrating into the infected
lungs revealed a strong neutrophilic infiltration starting
from day 3 in the young calves, which coincided with the
peak of clinical infection around day 8 and decreased
thereafter (Fig. 4). Neonates revealed significantly more
neutrophilic granulocytes at day 0, which decreased there-
after and peaked again at day 13 (as a result of one calf,
#9069). Higher percentages of neutrophilic granulocytes
were found in bronchoalveolar lung fluid (BALF) samples
in the young calves at days 6 (P50.0714) and 9 (P5
0.0317) p.i. compared with neonates. Blood smear analyses
showed overall significantly higher percentages of neutro-
phils in neonates compared with young calves (Fig. 5;
P,0.001). In young calves, a clear drop in peripheral blood
neutrophils was observed on day 10 p.i. compared with
day 9 p.i. (8.2±2.7 vs 16.4±7.0%, respectively; P50.06).
The bronchoalveolar lung cell (BALC) counts and numbers
of macrophages and lymphocytes in lung lavage samples
collected on study days 0, 3, 6, 9 and 13 are summarized in
Fig. 4.
BALF samples were analysed using a SearchLight Bovine
Cytokine Array for interleukin-4 (IL-4), IL-6, tumour
necrosis factor alpha (TNF-a) and gamma interferon
(IFN-c) (Fig. 6). Significantly higher levels of TNF-a were
measured in young calves versus neonates (overall mean
705.6±304.4 vs 303.9±109.1 pg ml21, respectively; P,
0.05). Significantly higher levels of IL-6 were measured in
neonates versus young calves (overall mean 958.5±231.4 vs
612.7±169.1 pg ml21, respectively; P,0.05). For IL-4, a
significant difference (P,0.05) was measured on study
day 9. For IFN-c, a significant difference was observed, but
only on day 6 p.i. (P,0.05). Higher IFN-c BALF levels
(mean 2391 pg ml21) were measured in young calves
compared with neonates (mean 74.12 pg ml21).
The partial pressure of O2 (pO2) in arterial blood samples
directly reflects the lung’s ability to oxygenate blood and
thus low levels are indicative of lung damage. A clear drop
in the supply of oxygen was observed around the peak of
infection, corresponding to the observed clinical signs of
LRTD and increased respiratory rates (Fig. 7). This drop
(mean values below 70 mmHg, reference/normal arterial
Fig. 3. Clinical observations. Mean clinical scores (±SEM) per group from day ”1 (prior to infection on day 0) until the end of
the study (day 13). &, Six-week-old young calves; g, 1-day-old neonates. RT, Rectal temperature.
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pO2 value is .85 mmHg; Coghe et al., 2000) between
days 7 and 9 was observed in both age groups. CO2
retention was not observed.
Haptoglobin is a major acute-phase protein in cattle and is
considered a good indicator of the host response to bRSV
(Heegaard et al., 2000). Plasma lactate is widely used as an
indicator of anaerobic metabolism, which reflects the
severity of disease (Coghe et al., 2000). Mean concentrations
are shown in Fig. 7. Prior to inoculation, plasma lactate
concentrations (mean±SEM) were significantly higher in
neonates than in young calves (4.04±0.79 vs 0.94±
0.14 mmol l21, respectively; P,0.0001; Fig. 7). Following
infection, no significant differences in plasma lactate
concentrations were observed between neonates and young
calves.
Upon inoculation, significantly higher haptoglobin con-
centrations (mg ml21) were detected in young calves
compared with neonates (overall mean±SD 123.5±
46.63 vs 79.27±31.73 mg ml21, respectively; P,0.05). A
positive correlation (r50.2833, P,0.001) between rectal
body temperature and haptoglobin concentrations was
observed.
Pathology
At necropsy, the overall percentages of consolidated lung
tissue area ranged from 0 to 5.1%. The mean percentage
(±SD) of consolidated lung tissue area in neonates was
significantly higher compared with young calves (2.35±
1.51 vs 0.35±0.36%, respectively; P,0.05). When con-
solidated lung areas were scored as described by Viuff et al.
(2002), four of five neonates scored 1, whilst all young calves
scored 0. Calves of both groups developed multifocal
bronchointerstitial pneumonia, with a marked proliferation
Fig. 4. Mean numbers of cells (+SEM) recovered (expressed as cells ml”1) from BALF samples per group from day ”1 (prior to
infection on day 0) until the end of the study period (day 13). &, Six-week-old young calves; g, 1-day-old neonates. BALC,
Bronchoalveolar lung cells.
Fig. 5. Mean percentages of peripheral neutrophils (+SEM) per
group from day 0 (prior to infection) until the end of the study
period (day 13). &, Six-week-old young calves; g, 1-day-old
neonates.
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of bronchiolar epithelium. Bronchioles were narrow and
often filled with secretion. It should be noted that calf #9069
did not have any consolidated lung area.
DISCUSSION
To study the effect of age on the pathogenesis of bRSV
infection in the absence of maternal antibodies, we
compared the clinical representation of disease in colos-
trum-deprived neonatal (1-day-old) and young (6-week-
old) calves. To our knowledge, the study reported here is
the first to describe differences in bRSV infection in
neonates and young calves of these ages.
We observed no severe disease in the neonates following
experimental bRSV infection. Kimman et al. (1988)
observed similar effects after natural infection (no clinical
disease in calves irrespective of the maternal antibody
titre), but hypothesized that this was due to a low virus
exposure. Here, we have provided evidence that this
hypothesis is not correct. In the current study, neonates
were clinically less affected than the young calves, despite a
longer period of virus replication and increased lung
pathology. Thus, direct cytopathology plays a minor role in
bRSV pathogenesis, and a role of immune mechanisms in
causing clinical symptoms is suggested.
Most cases of severe RSV disease in the field are observed in
1–3-month-old calves, when the calves possess maternally
derived neutralizing antibodies but at lower levels than at
birth. The possible influence of maternally derived anti-
bodies (MDAs) on the outcome of disease remains a
controversial issue. Whilst high MDA levels are considered
to mitigate the disease, moderate to low MDA levels might
aggravate the disease by immunopathological mechanisms.
Because the highest neutralizing antibody titres are found
in the youngest individuals, one may suggest a relationship
between MDA titres and RTD severity. Our findings do not
support this notion, but instead suggest a role of dif-
ferences in immunocompetence between the different age
groups.
Although still a controversial issue, it has been concluded
from a number of studies that immunological factors play a
major role in the most severe type of pulmonary damage
associated with RSV infection (Coomber et al., 2001;
Heegaard et al., 2000; Rontved et al., 2000). This view has
evolved from unusual epidemiological patterns of RSV
disease and from attempts to interpret the altered reactivity
to RSV infections observed after primary vaccination.
Apparently, the virus in the respiratory tract by itself does
not explain the severe disease manifestations. Tregoning
et al. (2008) demonstrated in BALB/c mice that a neonatal
(aged 4 days) human RSV (hRSV) infection was associated
Fig. 6. Mean cytokine measurements (+SEM) in BALF samples per group from day 0 (prior to infection) until the end of the
study period (day 13). Statistically significant time points (P,0.05) are indicated by an asterisk. The calculated P value for IL-6
on day 9 was 0.07 (#). &, Six-week-old young calves; g, 1-day-old neonates.
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with less inflammation and disease than in immature
adults (aged 4–6 weeks) and suggested that this was due to
different cytokine production profiles of cells recruited to
the site of infection.
To control, as far as possible, endogenous flora such as
Pasteurella spp., Haemophilus somnus and Mycoplasma
spp., we decided to use Caesarean-derived rather than
conventionally raised calves in this study. After birth, the
calves were kept in our own highly controlled animal
facilities (different hygiene barriers and HEPA-filtered
ingoing air), to maintain animals free of major bovine
pathogens. In this way, the pathological bRSV infection
was not complicated by pathogenic secondary bacterial
infections. Considering this, there is a possibility that
clinical signs noted in our study may have been less severe
than would have been the case under field conditions,
where bacterial superinfections are considered to have a
major effect on the course of the disease (Angen et al.,
2009; Babiuk et al., 1988).
It was concluded previously by others that an influx of
neutrophils in the lung tissue of animals experiencing
bovine respiratory disease resulted from secondary bac-
terial infections (Haslett, 1999; Slocombe et al., 1985;
Soethout et al., 2004). However, in this study we observed a
profound influx of neutrophils in the absence of a sec-
ondary bacterial superinfection. Moreover, we observed
intriguing different neutrophil infiltrations in the lungs of
neonatal and young calves. It is tempting to speculate that
this difference was caused by the different activation of
pro-inflammatory cytokines, in particular TNF-a.
Young calves showed a clear drop in peripheral blood
neutrophils on day 10 p.i. (Fig. 5). Lukens et al. (2010)
described an increase in neutrophil precursors for hRSV
patients between days 7 and 9 after the onset of symptoms
and this subsided a few days later (Lukens et al., 2010). All
of their patients required mechanical ventilation because of
respiratory failure due to an LRTD, which could have
induced an enhanced neutrophil activation. Lukens et al.
Fig. 7. Mean arterial pO2 and pCO2 values and mean concentrations of plasma lactate and haptoglobin (±SEM) per group from
day ”1 (prior to infection on day 0) until the end of the study period (day 13). &, Six-week-old young calves; g, 1-day-old
neonates. Haptoglobin concentrations were significantly higher on days 6 and 8 p.i. (*P,0.05). The blood gas status of
newborn calves differed significantly from that of 6-week-old calves; pO2 was significantly lower in 1-day-old than in 6-week-
old calves (73.6±11 vs 89.2±7.5 mmHg; P,0.05). There was a significant increase (P,0.01) in pO2 on the second day of
life compared with the first day of life (89.6±14.6 vs 73.6±11 mmHg), which was considered to be caused by adaptation of
the neonatal mechanics of breathing to extra-uterine life in the newborn calves (Varga et al., 1998). A clear drop in the supply of
oxygen was observed around day 8 p.i., corresponding to the observed peak in the LRTD clinical signs and respiratory rates
(not shown). This drop was observed in both age groups, but was more profound in the 6-week-old calves (days 7–9, mean
values ,70 mmHg). CO2 retention was not observed.
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(2010) started measuring cell levels 3–8 days after the onset
of symptoms, which would have been approximately
days 10–15 p.i. in our study.
The pattern of cytokine and chemokine expression induced
during the innate immune response activates migration of
immune cells (macrophages, eosinophils, basophils, neu-
trophils and natural killer cells) to the sites of infection,
regulates B- and T-cell activation and may enhance viral
clearance or exacerbate disease (Decleva et al., 2002;
Janssen et al., 2007; Rutigliano & Graham, 2004). We
evaluated expression of four cytokines in our study: IL-4,
IL-6, IFN-c and TNF-a. No overall significant differences
in expression of IL-4 and IFN-c were observed, although a
significant increase in IFN-c expression after infection was
observed in young calves, with a significantly higher
expression (P,0.05) observed on day 6 p.i. compared
with neonates. On the other hand, IL-4 expression
appeared to be higher in the neonates. TNF-a expression
was overall significantly higher in young calves and IL-6
overall in the neonates.
TNF-a is a pro-inflammatory cytokine produced by
activated cells of the monocyte–macrophage lineage that
provides a rapid form of host defence against various
infectious agents. TNF-a is known as a potent mediator of
inflammation and plays a key role during the inflammatory
responses of hRSV bronchiolitis (Becnel et al., 2005;
McNamara et al., 2004; Morrison et al., 2007). TNF-a
may play a protective role in RSV infection (Neuzil et al.,
1996). However, when in excess, TNF-a can provoke
chronic inflammatory disorders. You et al. (2006) recently
published the results of a study in a neonatal-mouse model
and suggested that TNF-a plays a key role in mediating
chronic inflammation (e.g. asthma) of the bronchi after
RSV infection. Tight regulation of TNF-a levels might
therefore be essential to separate its beneficial from its
harmful effects. Indeed, our data also showed that young
calves with more severe clinical disease had significantly
higher TNF-a levels than newborn calves, indicating that
alveolar macrophages from young calves produce more
TNF-a than alveolar macrophages from newborn calves.
Neutrophils respond to TNF-a with a respiratory burst
after a b2-integrin-dependent adherence to extracellular
matrix proteins (Decleva et al., 2002). TNF-a has been
proposed as an ideal drug target for the therapy of RSV-
induced bronchiolitis (Rutigliano & Graham, 2004; You
et al., 2006). Overall, our study points to a role for innate
immunity in RSV disease, a conclusion that was also drawn
from a genetic-association study in children (Janssen et al.,
2007).
Why alveolar macrophages in young calves produce more
TNF-a remains a subject for further study. Mallard et al.
(1998) published substantial evidence that both innate and
acquired defence mechanisms are lowest from 3 weeks pre-
calving to 3 weeks post-calving. Mallard et al. (1998)
concluded that calves are born with a functional immune
system and are capable of responding to certain antigenic
stimuli, but that the system does not yet operate at the
optimum response capacity. Chase et al. (2008) reported
that the innate response mediated by phagocytic cells
(neutrophils and macrophages) declines in functional
capacity around birth, due to an increase in fetal cortisol
levels. However, there is conflicting evidence about the
bovine neonatal innate response. For example, other papers
have shown that phagocytosis, respiratory burst and
bactericidal activity of calf neutrophils are intact and
functional from the first week of life (Kampen et al., 2006);
a reduced percentage of phagocytosing cells has been
reported in neonatal calves compared with older calves
(Menge et al., 1998); and neonatal macrophages have been
reported to exhibit enhanced phagocytic activity and
oxidative burst activity (Menge et al., 1998). Such
conflicting data might result from differences in experi-
mental protocols and read-out parameters. Further studies
are clearly required to address these important issues in
more detail.
Another interesting finding in our study was the absence of
detectable neutralizing antibody responses in some of the
neonatal calves. Significantly lower neutralizing serum
antibody titres (P,0.05) appeared by 13 days p.i. in
neonates compared with young calves. These findings were
largely confirmed by ELISA (data not shown). The ability
to respond to viral surface glycoproteins with a protective
antibody response appears to be acquired gradually over
the first months of life. It is thus likely that the limited
antibody response is explained by an inefficient antigen
presentation and T-helper-cell response due to immuno-
logical immaturity (Delespesse et al., 1998; Siegrist, 2001).
Another explanation could be a limited number of
circulating B cells in neonates (Chase et al., 2008).
However, despite lower numbers of B cells, such calves
may have the capacity to respond to an antigen (Kampen
et al., 2006).
Although further studies are needed, it appears that
differences in immune responses, in particular of the
natural and pro-inflammatory immune response, are
responsible for the differences in clinical appearance of
bRSV infection in newborn versus young calves. Despite
the presence or absence of maternally derived antibodies,
neonates do not appear to become severely ill, probably
due to immune incompetence. This is despite the fact that
the virus replicates to higher levels in neonates than in 6-
week-old (young) calves. During the process of maturation
of the immune system, disease can even be aggravated in
the first few months of life, but, at an older age when the
immune system is fully functioning, healthy cattle appear
to easily resist (severe) bRSV disease.
METHODS
Calves. Two groups of five specific-pathogen-free (SPF) calves were
obtained by Caesarean section at full term with 6 weeks in between to
reach an identical age difference. All calves were kept colostrum-
deprived and were housed in one large isolation room. All calves were
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tested to be free of bovine viral diarrhea virus (BVDV), as shown by a
BVDV antigen ELISA test kit (IDEXXHerdchek), and free of antibodies
directed against bRSV (Ceditest BRSV; Cedi Diagnostics BV).
Inoculation. Calves were inoculated as described previously (Antonis
et al., 2003). Briefly, calves were inoculated intranasally with an air-jet
nebulizer with bRSV strain Odijk on the same day when they were
6 weeks of age (young calves) or 1 day old (neonates). bRSV strain
Odijk was obtained during a field outbreak in Odijk, the Netherlands,
in 1991 (van der Poel et al., 1996). The inoculum (2 ml per calf) used
in this study contained 103.1 TCID50 bRSV ml
21, after being passaged
four times in vivo in SPF calves.
Clinical investigations. Calves were clinically examined daily by the
same veterinarian and scored for signs of general illness (reduced
responsiveness, decreased appetite, depression and/or retreats),
URTD (coughing, nasal/ocular discharge) and LRTD (hyperpnoea
and dyspnoea). Rectal temperatures and respiratory rates were also
recorded. The severity of the clinical disease was expressed by
allocating a weighing factor for each observation, varying from 1
(mild) to 3 (severe).
Laboratory investigations. Blood samples from the jugular vein
were collected daily from day 0 until the end of the experiment. Full
blood samples were collected for bRSV serology and heparinized
blood samples for haematological examination. The total numbers of
white blood cells, red blood cells and platelets were determined by
using a Coulter counter (Sysmex). Additionally, a blood smear
analysis was performed for differential counts of leukocytes. Blood
smears were stained using a Hema-Tek slide stainer.
Nasopharyngeal brush samples were obtained daily from day 0 until
the end of the experiment. Samples were collected using sterile nylon
bristle swabs (MW126; Medical Wire and Equipment). Following
sampling, swabs were agitated in 2 ml tissue culture medium
supplemented with antibiotics and FCS.
BALF samples were obtained on days 0 (day of inoculation, prior to
virus administration), 3, 6, 9 and 13. BALF samples were obtained as
described by Fogarty et al. (1983). Approximately 35–75 ml BALF was
obtained from each calf after instillation of 100 ml PBS. Foam, large
purulent exudates and blood clots were removed from the BALF
samples under aseptic conditions. BALF sample material was
inoculated onto sheep blood agar plates and incubated under aerobic
conditions at 37 uC. Bacteria were identified using standard lab-
oratory procedures. BALF sample material (2 ml) was centrifuged for
5 min at 25 g in a cytocentrifuge (Shandon Cytospin 2). Slides were
air-dried and fixed in methanol for 10 min at room temperature. A
total of 400 cells was counted (Hema-Tek slide stainer), and
macrophages, lymphocytes, monocytes and neutrophils were differ-
entiated on the basis of morphology. The remaining BALF was
centrifuged (200 g, 10 min, 4 uC). Lavage cells were resuspended in
0.5 ml Dulbecco’s minimal essential medium (DMEM) containing
1% antibiotic cocktail and 50% FCS, carefully added to 1 ml freeze
medium (DMEM containing 1% antibiotic cocktail, 50% FCS and
20% DMSO) and frozen at 270 uC. BALF supernatants were stored
at 270 uC for virus isolation and virus titration.
Virus isolations were performed in duplicate from BALF and
nasopharyngeal brush samples as described previously (van der Poel
et al., 1996) and positive samples were titrated in an end-point
titration.
Serum samples collected on days 0, 7 and 14 were tested for the
presence of virus-neutralizing antibodies in a virus neutralization
assay (Langedijk et al., 1996).
Arterial blood samples were collected daily from the caudal auricular
artery of the ear (intermediate or lateral branch) by puncture of the
vessel with a 25 gauge (0.5616 mm) needle after which the running
blood was drawn into a heparinized capillary. Rectal temperature was
measured simultaneously with blood sampling. After sampling, the
capillaries were closed immediately and stored on ice until analysis in
a pH/blood gas analyser (IL Synthesis; Instrumentation Laboratory)
for measurement of arterial pH, pCO2 and pO2 with correction for
rectal body temperature.
Venous blood samples were collected once daily from the jugular vein
in heparinized vacutainer tubes and stored on ice until determination
of plasma lactate concentrations (mmol l21) using Accutrend Lactate
and BM-Lactate test strips (Roche Diagnostics).
Haptoglobin was determined daily in serum with a haptoglobin assay
(Tridelta). This assay is based on the preservation of haemoglobin
peroxidase activity by haptoglobin in these samples. Haptoglobin
concentrations were read from a standard curve.
Bovine cytokines in serum and culture supernatants (IL-4, IL-6, IFN-c
and TNF-a) were determined quantitatively using a SearchLight
Bovine Cytokine Array (Pierce Biotechnology). Briefly, each well of a
microplate was pre-spotted with cytokine-specific antibodies (anti-
bodies against four cytokines per well). These antibodies capture
specific cytokines in each well. After the supernatant was washed
away, biotinylated detecting antibodies were added that bound to a
second site on the target proteins. After removing excess detecting
antibody, streptavidin–horseradish peroxidase was added. Finally, a
chemiluminescent substrate was added to produce a luminescent
signal that was detected with a cooled CCD camera. The amount of
signal produced was proportional to the amount of each cytokine in
the original standard or sample.
Post-mortem investigations. Thirteen days after virus inoculation,
calves were anaesthetized using pentobarbital and euthanized by
exsanguination. The lungs were removed immediately, and photo-
graphs of dorsal and ventral parts of the lungs were taken. From these
photographs, the extent of macroscopic lesions (consolidated lung
area) was scored on a scale of 0 to 5 as described by Viuff et al. (2002).
Necropsy samples of ten pre-determined sites were stored in 10%
neutral-buffered formalin. Formalized samples were embedded in
paraffin, and 5 mm sections were cut and stained with haematoxylin
and eosin for histological evaluation. Histological examination was
performed on the right middle lobe, the cranial part of the right
caudal lobe, the cranial part of the left caudal lobe and the left middle
lobe.
Statistical analysis. GraphPad Prism software was used for analysis
of the data. A two-way analysis of variance and non-parametric
(Mann–Whitney) test were used for comparisons. Correlations and
differences were considered significant for P,0.05.
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